AIRS logo

AirSculpt Technologies Inc. (AIRS)

$2.13

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on AIRS

Market cap

$153562795

EPS

-0.18

P/E ratio

--

Price to sales

1.14

Dividend yield

--

Beta

2.266135

Price on AIRS

Previous close

$2.38

Today's open

$2.40

Day's range

$2.10 - $2.40

52 week range

$1.51 - $12

Profile about AIRS

CEO

Yogesh Jashnani

Employees

422

Headquarters

Miami Beach, FL

Exchange

NASDAQ Global Market

Shares outstanding

72095209

Issue type

Common Stock

AIRS industries and sectors

Healthcare

Healthcare Providers & Services

News on AIRS

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AirSculpt Technologies, Inc. - AIRS

NEW YORK, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of AirSculpt Technologies, Inc. (“AirSculpt” or the “Company”) (NASDAQ: AIRS).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

news source

GlobeNewsWire • Sep 15, 2026

news preview

Plastic surgery is booming with boomers. Here's how to cash in on the antiaging craze.

Americans age 65 and older are suddenly the fastest-growing customers for cosmetic surgery.

news source

Market Watch • Sep 5, 2026

news preview

AirSculpt Sees Core Stabilization, Targets $100M-Plus GLP-1 Opportunity

AirSculpt Technologies NASDAQ: AIRS is seeing stabilization in its core body-contouring business after several quarters of declines, while expanding services aimed at patients using GLP-1 weight-loss drugs, Chief Executive Officer Yogi Jashnani said at a Canaccord consumer conference.

news source

MarketBeat • Aug 11, 2026

news preview

AirSculpt Technologies Q2 Earnings Call Highlights

AirSculpt Technologies NASDAQ: AIRS reported second-quarter revenue of $42.9 million, down 2.5% from the prior-year period, as the company cited stable revenue trends, positive same-center case growth and continued investment in marketing and expanded procedure offerings.

news source

MarketBeat • Aug 10, 2026

news preview

AirSculpt Technologies, Inc. (AIRS) Q2 2026 Earnings Call Transcript

AirSculpt Technologies, Inc. (AIRS) Q2 2026 Earnings Call Transcript

news source

Seeking Alpha • Aug 10, 2026

news preview

AirSculpt Technologies Reports Second Quarter Fiscal 2026 Results

MIAMI BEACH, Fla., Aug. 10, 2026 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)(“AirSculpt” or the “Company”), a national provider of premium body contouring procedures, today announced results for the second quarter ended June 30, 2026.

news source

GlobeNewsWire • Aug 10, 2026

news preview

Airsculpt Technologies, Barrick Mining And Other Big Stocks Moving Lower In Monday's Pre-Market Session

U.S. stock futures were mixed this morning, with the Dow futures falling around 0.1% on Monday.

news source

Benzinga • Aug 10, 2026

news preview

AirSculpt Technologies Announces Earnings Release Date, Conference Call, and Webcast for Second Quarter Fiscal 2026 Results

Company to Participate in Canaccord Genuity's 46th Annual Growth Conference Company to Participate in Canaccord Genuity's 46th Annual Growth Conference

news source

GlobeNewsWire • Aug 3, 2026

news preview

AIRS Medical Welcomes Strategic Growth Investment from TA Associates to Accelerate Global Growth in AI-Powered MRI Solutions

HONG KONG & SEOUL, South Korea--(BUSINESS WIRE)--AIRS Medical (“the Company”), a global leader in AI solutions for medical imaging, today announced a strategic growth investment from TA Associates (“TA”), a leading global private equity firm. The investment will help fuel AIRS Medical's next phase of global expansion, advancement of its AI-powered radiology technology solutions and ongoing product innovation. Founded in 2018, AIRS Medical develops AI-native magnetic resonance imaging (“MRI”) ac.

news source

Business Wire • Jun 16, 2026

news preview

AirSculpt Technologies Announces Participation in Upcoming Investor Conferences

MIAMI BEACH, Fla., May 27, 2026 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (“AirSculpt” or the “Company”) (NASDAQ: AIRS), an industry leader and provider of premium body contouring procedures, today announced that the Company will participate in upcoming investor conferences.

news source

GlobeNewsWire • May 27, 2026

news preview

¹ Disclosures

Get started with M1

Invest in AirSculpt Technologies Inc.

Open an M1 investment account to buy and sell AirSculpt Technologies Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in AIRS on M1